Synlait Milk Posts $80.6M Loss but Eyes $307M Asset Sale to Fund Turnaround

By John Zadeh -

Synlait presents recovery roadmap

Synlait Milk Limited has presented its Synlait Milk Recovery Roadmap HY26 to investors following a challenging half-year ended 31 January 2026. The dairy producer reported a Total Group EBITDA loss of ($34.7M) and a Total Group NPAT loss of ($80.6M), whilst unveiling a structured turnaround strategy centred on three horizons: Stabilise, Simplify, and Scale. Management withdrew financial guidance for the remainder of FY26, with net debt standing at $472.1M. The company is progressing the sale of its North Island assets to Abbott for approximately NZ$307 million, expected to complete on 1 April 2026.

What went wrong in HY26

Synlait’s HY26 result reflects a cascade of operational disruptions that began with manufacturing challenges in the second half of FY25. The sequence unfolded as follows:

  1. Inventory shortfall created by FY25 manufacturing issues requiring customer inventory rebuilds
  2. Manufacturing plan adjustments to focus on catch-up production
  3. Tactical milk sales necessitated by surplus milk during peak season
  4. Pivoting under pressure when milk sales plans faltered, forcing production shifts to whole milk powder
  5. Global downturn in WMP pricing at the end of calendar year 2025, creating unfavourable Ingredients returns

This perfect storm drove Ingredients gross profit down 89% year-on-year and contributed to an operating cash outflow of ($183.4M). Synlait has lodged an insurance claim expected to recover a portion of losses relating to the FY25 manufacturing challenges, though customer inventory levels are still being rebuilt.

What is a turnaround strategy?

A corporate turnaround strategy is a structured approach companies deploy when facing operational or financial distress. It typically follows a staged recovery model: first halting deterioration (stabilise), then streamlining operations (simplify), and finally pursuing growth (scale). Investors monitor turnaround credibility through early execution signals such as cost reduction delivery, management team renewal, and customer relationship stability. The framework helps differentiate temporary operational disruptions from structural business failures, providing a roadmap for assessing recovery progress.

Where Synlait’s recovery stands today

Synlait’s “Horizon One” (Stabilise) phase is already activating across four operational pillars:

Pillar Key Actions Delivered
Quality & Operations New Quality Strategy delivered; Synlait Care programme implemented company-wide; environmental controls and testing capabilities expanded
Revenue Business development team strengthened; customer-centric culture shift underway; Palmerston North office closure delivering over $2M per year benefit
Milk Supply North Island exit down to 7 farms for final season; Canterbury supply aligned for 2026/27 with 3 new farms joining
People & Culture Executive Leadership Team renewed; Synlait Spirit values launched; frontline leadership training strengthened

The Canterbury-focused operational model represents a strategic simplification, with the North Island divestment removing a drag that contributed ($7.9M) EBITDA loss in HY25 and ($2.7M) in HY26.

Business unit performance shows bright spots amid challenges

Whilst Ingredients gross profit collapsed 89% on volume and price impacts, other business units demonstrated underlying resilience:

  • Consumer: Revenue up 51%, gross profit up 22%, driven by Dairyworks export growth, new private label contracts, and Australian expansion through Woolworths and Costco
  • Foodservice: Revenue up 48%, moving from negative to positive margin territory; UHT volumes surged 24% as traction built in China and Southeast Asia
  • Advanced Nutrition: Gross profit impacted by operational pressures (down 87%), though strategic progress continues with new customer trials in the Middle East and ongoing US Food & Drug Administration infant formula submission work with The a2 Milk Company

The Consumer and Foodservice momentum indicates core business strength masked by Ingredients volatility. Synlait’s recent accreditation under the Ministry of Primary Industries Grass-Fed scheme provides a competitive advantage for future Ingredients and Advanced Nutrition positioning.

Balance sheet and milk price outlook

Net debt reached $472.1M at balance date, up $80.2M on the prior year due to operational challenges and working capital pressures. Financing costs decreased 49% following refinancing and lower base rates, with the introduction of lower-cost RMB funding aligned to Chinese Yuan-denominated business.

Synlait’s milk price guidance for the 2025/26 season comprises a $9.50 base price plus $0.30 average incentive plus $0.10 secured milk premium, totalling a forecast $9.90/kgMS average payment to farmers. The secured milk premium applies across FY26, FY27, and FY28 seasons for committed suppliers.

Post balance date, Synlait secured banking covenant amendments providing recovery runway. Interest cover ratio has been set at no less than 0.25x for 30 April 2026 and 31 July 2026 reporting dates (waived for 31 January 2026), whilst the net senior debt to EBITDA ratio has been suspended for 31 July 2026. The $130M shareholder loan from Bright Dairy International Investment Limited matures 12 July 2026, with Bright Dairy providing preliminary indication of continued support subject to relevant approvals.

What investors should watch next

Near-term catalysts for the Synlait Milk Recovery Roadmap HY26 include:

  • 1 April 2026: North Island asset sale completion to Abbott (circa NZ$307 million)
  • Mid-2026: HY26 insurance claim outcome related to FY25 manufacturing losses
  • 12 July 2026: Bright Dairy shareholder loan maturity and refinancing resolution

Medium-term focus areas centre on Ingredients margin recovery as production stabilises, Consumer and Foodservice volume expansion into Asian markets, and FDA approval progress for The a2 Milk Company’s infant formula submission. The Grass-Fed MPI certification provides differentiation for premium product positioning, particularly in markets prioritising traceability and sustainability credentials.

Richard Wyeth, CEO

“We are focused on delivering operational stability that meets customer expectations, strengthens financial resilience, and builds greater optionality for Synlait’s future.”

The three-horizon recovery roadmap signals management’s structured approach to addressing operational issues whilst preserving strategic customer relationships. Execution of the Stabilise phase will determine whether Synlait can transition to the Simplify and Scale horizons as intended, with the North Island divestment representing a critical step in balance sheet repair and operational focus.

Want the Next Consumer Breakout in Your Inbox?

Join 20,000+ investors getting FREE breaking ASX news delivered within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to receive market-moving Consumer announcements the moment they hit the ASX, with expert coverage already done for you.


Frequently Asked Questions

What is the Synlait Milk Recovery Roadmap HY26?

The Synlait Milk Recovery Roadmap HY26 is a structured turnaround strategy presented to investors following a half-year NPAT loss of ($80.6M), organised across three horizons: Stabilise, Simplify, and Scale. It outlines specific operational actions across quality, revenue, milk supply, and people pillars to restore financial and operational performance.

Why did Synlait Milk report such a large loss in HY26?

Synlait's HY26 loss was primarily driven by an 89% collapse in Ingredients gross profit, caused by a cascade of events including FY25 manufacturing challenges, inventory shortfalls, forced pivots to whole milk powder production, and a global downturn in WMP pricing at the end of 2025. This resulted in an operating cash outflow of ($183.4M) for the half.

When will Synlait complete the sale of its North Island assets to Abbott?

Synlait expects to complete the sale of its North Island assets to Abbott for approximately NZ$307 million on 1 April 2026. The divestment is a key step in the company's balance sheet repair and strategic refocus on its Canterbury operations.

What are the key risks investors should monitor in Synlait's turnaround?

The most immediate risk is the maturity of the $130M Bright Dairy shareholder loan on 12 July 2026, where only a preliminary indication of continued support has been provided. Additional risks include the ongoing Ingredients margin recovery timeline, the outcome of the HY26 insurance claim, and the execution credibility of the three-horizon roadmap given recent operational failures.

Is there any positive business momentum within Synlait despite the losses?

Yes — Synlait's Consumer segment delivered 51% revenue growth and 22% gross profit growth, while Foodservice revenue rose 48% with UHT volumes up 24% in China and Southeast Asia. These results indicate meaningful underlying commercial strength that has been masked by the Ingredients segment disruption.

John Zadeh
By John Zadeh
Founder & CEO
John Zadeh is a investor and media entrepreneur with over a decade in financial markets. As Founder and CEO of StockWire X and Discovery Alert, Australia's largest mining news site, he's built an independent financial publishing group serving investors across the globe.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher